{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T01:06:38Z","timestamp":1775696798421,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,5,25]],"date-time":"2012-05-25T00:00:00Z","timestamp":1337904000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s10384-012-0152-5","type":"journal-article","created":{"date-parts":[[2012,5,24]],"date-time":"2012-05-24T00:02:33Z","timestamp":1337817753000},"page":"312-318","source":"Crossref","is-referenced-by-count":26,"title":["Topical loteprednol etabonate 0.5\u00a0% for treatment of vernal keratoconjunctivitis: efficacy and safety"],"prefix":"10.1007","volume":"56","author":[{"given":"Veysi","family":"\u00d6ner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih Mehmet","family":"T\u00fcrkc\u00fc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Ta\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Fuat","family":"Alaku\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yal\u00e7\u0131n","family":"\u0130\u015fcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,25]]},"reference":[{"key":"152_CR1","first-page":"117","volume":"18","author":"WH Ehlers","year":"1992","unstructured":"Ehlers WH, Donshik PC. Allergic ocular disorders: a spectrum of diseases. CLAO J. 1992;18:117\u201324.","journal-title":"CLAO J"},{"key":"152_CR2","first-page":"95","volume":"70","author":"MB Abelson","year":"1993","unstructured":"Abelson MB, George MA, Garofalo C. Differential diagnosis of ocular allergic disorders. Ann Allergy. 1993;70:95\u2013109.","journal-title":"Ann Allergy"},{"key":"152_CR3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10384-005-0319-4","volume":"50","author":"J Shoji","year":"2006","unstructured":"Shoji J, Inada N, Sawa M. Antibody array-generated cytokine profiles of tears of patients with vernal keratoconjunctivitis or giant papillary conjunctivitis. Jpn J Ophthalmol. 2006;50:195\u2013204.","journal-title":"Jpn J Ophthalmol"},{"key":"152_CR4","first-page":"237","volume":"19","author":"P Kosrirukvongs","year":"2001","unstructured":"Kosrirukvongs P, Visitsunthorn N, Vichyanond P, Bunnag C. Allergic conjunctivitis. Asian Pac J Allergy Immunol. 2001;19:237\u201344.","journal-title":"Asian Pac J Allergy Immunol"},{"key":"152_CR5","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0161-6420(00)00092-0","volume":"107","author":"S Bonini","year":"2000","unstructured":"Bonini S, Bonini S, Lambiase A, Marchi S, Pasqualetti P, Zuccaro O, et al. Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup. Ophthalmology. 2000;107:1157\u201363.","journal-title":"Ophthalmology"},{"key":"152_CR6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00004397-200343010-00007","volume":"43","author":"A Leonardi","year":"2003","unstructured":"Leonardi A, Secchi AG. Vernal keratoconjunctivitis. Int Ophthalmol Clin. 2003;43:41\u201358.","journal-title":"Int Ophthalmol Clin"},{"key":"152_CR7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1350-9462(02)00006-X","volume":"21","author":"A Leonardi","year":"2002","unstructured":"Leonardi A. Vernal keratoconjunctivitis: pathogenesis and treatment. Prog Retin Eye Res. 2002;21:319\u201339.","journal-title":"Prog Retin Eye Res"},{"key":"152_CR8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2222.1999.00501.x","volume":"29","author":"PH Verin","year":"1999","unstructured":"Verin PH, Dicker ID, Mortemousque B. Nedocromil sodium eye drops are more effective than sodium cromoglycate eye drops for the long-term management of vernal keratoconjunctivitis. Clin Exp Allergy. 1999;29:529\u201336.","journal-title":"Clin Exp Allergy"},{"key":"152_CR9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1398-9995.1995.tb04254.x","volume":"50","author":"D BenEzra","year":"1995","unstructured":"BenEzra D. Current practice: diagnosis and treatment in primary healthcare. Allergy. 1995;50:30\u20133.","journal-title":"Allergy"},{"key":"152_CR10","first-page":"6","volume":"67","author":"SD Trocme","year":"1995","unstructured":"Trocme SD, Raizman MB, Bartley GB. Medical therapy for ocular allergy. Mayo Clin Proc. 1995;67:6\u20139.","journal-title":"Mayo Clin Proc"},{"key":"152_CR11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1755-3768.1978.tb05690.x","volume":"56","author":"T Jerndal","year":"1978","unstructured":"Jerndal T, Munkby M. Corticosteroid response in dominant congenital glaucoma. Acta Ophthalmol (Copenh). 1978;56:373\u201383.","journal-title":"Acta Ophthalmol (Copenh)."},{"key":"152_CR12","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ajo.2004.04.052","volume":"138","author":"SC Pflugfelder","year":"2004","unstructured":"Pflugfelder SC, Maskin SL, Anderson B, Chodosh J, Holland EJ, De Paiva CS, et al. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol. 2004;138:444\u201357.","journal-title":"Am J Ophthalmol"},{"key":"152_CR13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0091-6749(98)70094-6","volume":"102","author":"SJ Dell","year":"1998","unstructured":"Dell SJ, Lowry GM, Northcutt JA, Howes J, Novack GD, Hart K. A randomized, double-masked, placebo-controlled parallel study of 0.2% loteprednol etabonate in patients with seasonal allergic conjunctivitis. J Allergy Clin Immunol. 1998;102:251\u20135.","journal-title":"J Allergy Clin Immunol"},{"key":"152_CR14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.ICL.0000092071.82938.46","volume":"30","author":"H Ilyas","year":"2004","unstructured":"Ilyas H, Slonim CB, Braswell GR, Favetta JR, Schulman M. Long-term safety of loteprednol etabonate 0.2% in the treatment of seasonal and perennial allergic conjunctivitis. Eye Contact Lens. 2004;30:10\u20133.","journal-title":"Eye Contact Lens"},{"key":"152_CR15","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0886-3350(98)80170-3","volume":"24","author":"R Stewart","year":"1998","unstructured":"Stewart R, Horwitz B, Howes J, Novack GD, Hart K. Double-masked, placebo-controlled evaluation of loteprednol etabonate 0.5% for postoperative inflammation. Loteprednol Etabonate Post-operative Inflammation Study Group 1. J Cataract Refract Surg. 1998;24:1480\u20139.","journal-title":"J Cataract Refract Surg"},{"key":"152_CR16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0002-9394(14)70171-0","volume":"123","author":"MH Friedlaender","year":"1997","unstructured":"Friedlaender MH, Howes J. A double-masked, placebo-controlled evaluation of the efficacy and safety of loteprednol etabonate in the treatment of giant papillary conjunctivitis. Loteprednol Etabonate Giant Papillary Conjunctivitis Study Group I. Am J Ophthalmol. 1997;123:455\u201364.","journal-title":"Am J Ophthalmol"},{"key":"152_CR17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0002-9394(99)00034-3","volume":"127","author":"Loteprednol Etabonate US Uveitis Study Group","year":"1999","unstructured":"Loteprednol Etabonate US Uveitis Study Group. Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Loteprednol Etabonate US Uveitis Study Group. Am J Ophthalmol. 1999;127:537\u201344.","journal-title":"Am J Ophthalmol"},{"key":"152_CR18","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/eye.2011.75","volume":"25","author":"A Kheirkhah","year":"2011","unstructured":"Kheirkhah A, Zavareh MK, Farzbod F, Mahbod M, Behrouz MJ. Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis. Eye (Lond). 2011;25:872\u201380.","journal-title":"Eye (Lond)"},{"key":"152_CR19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000099294","volume":"221","author":"E Uchio","year":"2007","unstructured":"Uchio E, Itoh Y, Kadonosono K. Topical bromfenac sodium for long-term management of vernal keratoconjunctivitis. Ophthalmologica. 2007;221:153\u20138.","journal-title":"Ophthalmologica"},{"key":"152_CR20","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1208\/aapsj070479","volume":"7","author":"N Bodor","year":"2005","unstructured":"Bodor N, Buchwald P. Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical delivery systems. AAPS J. 2005;7:820\u201333.","journal-title":"AAPS J"},{"key":"152_CR21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/jop.1998.14.153","volume":"14","author":"J Howes","year":"1998","unstructured":"Howes J, Novack GD. Failure to detect systemic levels, and effects of loteprednol etabonate and its metabolite, pj-91, following chronic ocular administration. J Ocul Pharmacol Ther. 1998;14:153\u20138.","journal-title":"J Ocul Pharmacol Ther"},{"key":"152_CR22","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1350-9462(98)00035-4","volume":"18","author":"RJ Wordinger","year":"1999","unstructured":"Wordinger RJ, Clark AF. Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma. Prog Retin Eye Res. 1999;18:629\u201367.","journal-title":"Prog Retin Eye Res"},{"key":"152_CR23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/jop.1993.9.157","volume":"9","author":"JD Bartlett","year":"1993","unstructured":"Bartlett JD, Horwitz B, Laibovitz R, Howes JF. Intraocular pressure response to loteprednol etabonate in known steroid responders. J Ocul Pharmacol. 1993;9:157\u201365.","journal-title":"J Ocul Pharmacol"},{"key":"152_CR24","first-page":"266","volume":"7","author":"GD Novack","year":"1998","unstructured":"Novack GD, Howes J, Crockett RS, Sherwood MB. Change in intraocular pressure during long-term use of loteprednol etabonate. J Glaucoma. 1998;7:266\u20139.","journal-title":"J Glaucoma"},{"key":"152_CR25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/ICO.0b013e31815873c7","volume":"27","author":"EJ Holland","year":"2008","unstructured":"Holland EJ, Bartlett JD, Paterno MR, Usner DW, Comstock TL. Effects of loteprednol\/tobramycin versus dexamethasone\/tobramycin on intraocular pressure in healthy volunteers. Cornea. 2008;27:50\u20135.","journal-title":"Cornea"},{"key":"152_CR26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1185\/030079908X253898","volume":"24","author":"EM White","year":"2008","unstructured":"White EM, Macy JI, Bateman KM, Comstock TL. Comparison of the safety and efficacy of loteprednol 0.5%\/tobramycin 0.3% with dexamethasone 0.1%\/tobramycin 0.3% in the treatment of blepharokeratoconjunctivitis. Curr Med Res Opin. 2008;24:287\u201396.","journal-title":"Curr Med Res Opin"},{"key":"152_CR27","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/0014-4835(85)90130-7","volume":"40","author":"R Bucala","year":"1985","unstructured":"Bucala R, Gallati M, Manabe S, Cotlier E, Cerami A. Glucocorticoid-lens protein adducts in experimentally induced steroid cataracts. Exp Eye Res. 1985;40:853\u201363.","journal-title":"Exp Eye Res"},{"key":"152_CR28","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3109\/02713689109020329","volume":"10","author":"P Druzgala","year":"1991","unstructured":"Druzgala P, Wu WM, Bodor N. Ocular absorption and distribution of loteprednol etabonate, a soft steroid, in rabbit eyes. Curr Eye Res. 1991;10:933\u20137.","journal-title":"Curr Eye Res"},{"key":"152_CR29","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/bjo.2007.132621","volume":"92","author":"CE Pavesio","year":"2008","unstructured":"Pavesio CE, Decory HH. Treatment of ocular inflammatory conditions with loteprednol etabonate. Br J Ophthalmol. 2008;92:455\u20139.","journal-title":"Br J Ophthalmol"},{"key":"152_CR30","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000310839","volume":"211","author":"K Bilgihan","year":"1997","unstructured":"Bilgihan K, Gurelik G, Akata F, Hasanreisoglu B. Fluorometholone induced cataract after photorefractive keratectomy. Ophthalmologica. 1997;211:394\u20136.","journal-title":"Ophthalmologica"},{"key":"152_CR31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2133.1989.tb04181.x","volume":"120","author":"C Costagliola","year":"1989","unstructured":"Costagliola C, Cati-Giovannelli B, Priccirrillo A, Delfino M. Cataracts associated with long-term topical steroids. Br J Dermatol. 1989;120:472\u20133.","journal-title":"Br J Dermatol"},{"key":"152_CR32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10384-008-0577-z","volume":"52","author":"U Keklikci","year":"2008","unstructured":"Keklikci U, Soker SI, Sakalar YB, Unlu K, Ozekinci S, Tunik S. Efficacy of topical cyclosporin A 0.05% in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjunctivitis in children. Jpn J Ophthalmol. 2008;52:357\u201362.","journal-title":"Jpn J Ophthalmol"},{"key":"152_CR33","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jaci.2011.07.004","volume":"128","author":"A Lambiase","year":"2011","unstructured":"Lambiase A, Leonardi A, Sacchetti M, Deligianni V, Sposato S, Bonini S. Topical cyclosporine prevents seasonal recurrences of vernal keratoconjunctivitis in a randomized, double-masked, controlled 2-year study. J Allergy Clin Immunol. 2011;128:896\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"152_CR34","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1081-1206(10)61958-8","volume":"89","author":"N Pucci","year":"2002","unstructured":"Pucci N, Novembre E, Cianferoni A, Lombardi E, Bernardini R, Caputo R, et al. Effi cacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis. Ann Allergy Asthma Immunol. 2002;89:298\u2013303.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"152_CR35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jaci.2003.10.065","volume":"113","author":"P Vichyanond","year":"2004","unstructured":"Vichyanond P, Tantimongkolsuk C, Dumrongkigchaiporn P, Jirapongsananuruk O, Visitsunthorn N, Kosrirukvongs P. Vernal keratoconjunctivitis: result of a novel therapy with 0.1% topical ophthalmic FK-506 ointment. J Allergy Clin Immunol. 2004;113:355\u20138.","journal-title":"J Allergy Clin Immunol"},{"key":"152_CR36","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.4049\/jimmunol.139.6.1797","volume":"139","author":"S Sawada","year":"1987","unstructured":"Sawada S, Suzuki G, Kawase Y, Takaku F. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation. J Immunol. 1987;139:1797\u2013803.","journal-title":"J Immunol"},{"key":"152_CR37","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/ACI.0b013e32834a9652","volume":"11","author":"MH Friedlaender","year":"2011","unstructured":"Friedlaender MH. Ocular allergy. Curr Opin Allergy Clin Immunol. 2011;11:477\u201382.","journal-title":"Curr Opin Allergy Clin Immunol"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-012-0152-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10384-012-0152-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-012-0152-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T22:36:49Z","timestamp":1687473409000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10384-012-0152-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,25]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["152"],"URL":"https:\/\/doi.org\/10.1007\/s10384-012-0152-5","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,25]]}}}